130 related articles for article (PubMed ID: 25365268)
1. Cost-effectiveness of non-invasive assessment in the Dutch breast cancer screening program versus usual care: a randomized controlled trial.
Timmers JM; Damen JA; Pijnappel RM; Verbeek AL; den Heeten GJ; Adang EM; Broeders MJ
Can J Public Health; 2014 Jul; 105(5):e342-7. PubMed ID: 25365268
[TBL] [Abstract][Full Text] [Related]
2. Rapid Access to Contrast-Enhanced spectral mammogRaphy in women recalled from breast cancer screening: the RACER trial study design.
Neeter LMFH; Houben IPL; Nelemans PJ; Van Nijnatten TJA; Pijnappel RM; Frotscher C; Osinga-de Jong M; Sanders F; Van Dalen T; Raat HPJ; Essers BAB; Wildberger JE; Smidt ML; Lobbes MBI
Trials; 2019 Dec; 20(1):759. PubMed ID: 31870414
[TBL] [Abstract][Full Text] [Related]
3. Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT.
Clarkson JE; Pitts NB; Goulao B; Boyers D; Ramsay CR; Floate R; Braid HJ; Fee PA; Ord FS; Worthington HV; van der Pol M; Young L; Freeman R; Gouick J; Humphris GM; Mitchell FE; McDonald AM; Norrie JD; Sim K; Douglas G; Ricketts D
Health Technol Assess; 2020 Nov; 24(60):1-138. PubMed ID: 33215986
[TBL] [Abstract][Full Text] [Related]
4. Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness.
de Bock GH; Vermeulen KM; Jansen L; Oosterwijk JC; Siesling S; Dorrius MD; Feenstra T; Houssami N; Greuter MJ
Br J Cancer; 2013 Apr; 108(8):1579-86. PubMed ID: 23579217
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.
Geuzinge HA; Obdeijn IM; Rutgers EJT; Saadatmand S; Mann RM; Oosterwijk JC; Tollenaar RAEM; de Roy van Zuidewijn DBW; Lobbes MBI; van 't Riet M; Hooning MJ; Ausems MGEM; Loo CE; Wesseling J; Luiten EJT; Zonderland HM; Verhoef C; Heijnsdijk EAM; Tilanus-Linthorst MMA; de Koning HJ;
JAMA Oncol; 2020 Sep; 6(9):1381-1389. PubMed ID: 32729887
[TBL] [Abstract][Full Text] [Related]
6. Economic Evaluation of Web- versus Telephone-based Interventions to Simultaneously Increase Colorectal and Breast Cancer Screening Among Women.
Huang D; Lairson DR; Chung TH; Monahan PO; Rawl SM; Champion VL
Cancer Prev Res (Phila); 2021 Sep; 14(9):905-916. PubMed ID: 34244154
[TBL] [Abstract][Full Text] [Related]
7. Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysis.
Phi XA; Greuter MJW; Obdeijn IM; Oosterwijk JC; Feenstra TL; Houssami N; de Bock GH
Breast; 2019 Jun; 45():82-88. PubMed ID: 30904701
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of HPV-based cervical screening based on first year results in the Netherlands: a modelling study.
Jansen E; Naber SK; Aitken CA; de Koning HJ; van Ballegooijen M; de Kok I
BJOG; 2021 Feb; 128(3):573-582. PubMed ID: 32638462
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness evaluation of risk-based breast cancer screening in Urban Hebei Province.
Shi J; Guan Y; Liang D; Li D; He Y; Liu Y
Sci Rep; 2023 Feb; 13(1):3370. PubMed ID: 36849794
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of a pragmatic exercise intervention for women with breast cancer: results from a randomized controlled trial.
Gordon LG; DiSipio T; Battistutta D; Yates P; Bashford J; Pyke C; Eakin E; Hayes SC
Psychooncology; 2017 May; 26(5):649-655. PubMed ID: 27338125
[TBL] [Abstract][Full Text] [Related]
11. Dutch digital breast cancer screening: implications for breast cancer care.
Timmers JM; den Heeten GJ; Adang EM; Otten JD; Verbeek AL; Broeders MJ
Eur J Public Health; 2012 Dec; 22(6):925-9. PubMed ID: 22158996
[TBL] [Abstract][Full Text] [Related]
12. Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening.
Meenan RT; Troja C; Buist DSM; Tiro JA; Lin J; Anderson ML; Gao H; Green BB; Winer RL
JAMA Netw Open; 2023 Mar; 6(3):e234052. PubMed ID: 36947040
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer screening; cost-effective in practice?
De Koning HJ
Eur J Radiol; 2000 Jan; 33(1):32-7. PubMed ID: 10674787
[TBL] [Abstract][Full Text] [Related]
14. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
Schousboe JT; Kerlikowske K; Loh A; Cummings SR
Ann Intern Med; 2011 Jul; 155(1):10-20. PubMed ID: 21727289
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands.
Sankatsing VD; Heijnsdijk EA; van Luijt PA; van Ravesteyn NT; Fracheboud J; de Koning HJ
Int J Cancer; 2015 Oct; 137(8):1990-9. PubMed ID: 25895135
[TBL] [Abstract][Full Text] [Related]
16. Group cognitive rehabilitation to reduce the psychological impact of multiple sclerosis on quality of life: the CRAMMS RCT.
Lincoln NB; Bradshaw LE; Constantinescu CS; Day F; Drummond AE; Fitzsimmons D; Harris S; Montgomery AA; das Nair R
Health Technol Assess; 2020 Jan; 24(4):1-182. PubMed ID: 31934845
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of breast cancer screening in the National Breast and Cervical Cancer Early Detection Program.
Rim SH; Allaire BT; Ekwueme DU; Miller JW; Subramanian S; Hall IJ; Hoerger TJ
Cancer Causes Control; 2019 Aug; 30(8):819-826. PubMed ID: 31098856
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of an 18-week exercise programme for patients with breast and colon cancer undergoing adjuvant chemotherapy: the randomised PACT study.
May AM; Bosch MJ; Velthuis MJ; van der Wall E; Steins Bisschop CN; Los M; Erdkamp F; Bloemendal HJ; de Roos MA; Verhaar M; Ten Bokkel Huinink D; Peeters PH; de Wit GA
BMJ Open; 2017 Mar; 7(3):e012187. PubMed ID: 28264824
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
